Role of the Inducible Nitric Oxide Synthase in the Onset of Fructose-Induced Steatosis in Mice
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
To test the hypothesis that the inducible nitric oxide synthase (iNOS) is involved in mediating the toll-like receptor 4-dependent effects on the liver in the onset of fructose-induced steatosis, wild-type and iNOS knockout (iNOS(-/-)) mice were either fed tap water or 30% fructose solution for 8 weeks. Chronic consumption of 30% fructose solution led to a significant increase in hepatic steatosis and inflammation as well as plasma alanine-aminotransferase levels in wild-type mice. This effect of fructose feeding was markedly attenuated in iNOS(-/-) mice. Hepatic lipidperoxidation, concentration of phospho-IκB, nuclear factor κB activity, and tumor necrosis factor-α mRNA level were significantly increased in fructose-fed wild-type mice, whereas in livers of fructose-fed iNOS(-/-) mice, lipidperoxidation, phospho-IκB, nuclear factor κB activity, and tumor necrosis factor-α expression were almost at the level of controls. However, portal endotoxin levels and hepatic myeloid differentiation factor 88 expression were significantly higher in both fructose-fed groups compared to controls. Taken together, these data suggest that (i) the formation of reactive oxygen species in liver is a key factor in the onset of fatty liver and (ii) iNOS is involved in mediating the endotoxin/toll-like receptor 4-dependent effects in the development of fructose-induced fatty liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890 · cited 1×
“Further, steatosis can progress to stea-tohepatitis, increasing the probability of further liver-related morbidity and mortality (4).”
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319 · cited 1×
“In the present study, not only plasma TNF a levels but also RBP4 plasma concentration, both parameters indicating insulin resistance (16, 33, 43), were markedly higher in wild-type mice chronically fed fructose, whereas these parameters were at the levels of controls in iNOS (cid:2) = (cid:2) mice.”
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604
High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo
Mantena, S. K., Vaughn, D. P., Andringa, K. K., Eccleston, H. B., King, A. L., Abrams, G. A., Doeller, J. E., Kraus, D. W., Darley-Usmar, V. M., & Bailey, S. M. (2009) · Biochemical Journal · doi:10.1042/bj20080868 · Cited by 265 · cited 2×
“…derived from an induction of iNOS in the liver may be a critical factor in the onset of NAFLD and are with this in line with most other reports studying the role of iNOS in the onset and progression of metabolic liver diseases ( e.g. , alcoholic and nonalcoholic fatty liver disease) (25, 34, 37).”
McKim, S. E., Gäbele, E., Isayama, F., Lambert, J. C., Tucker, L. M., Wheeler, M. D., Connor, H. D., Mason, R. P., Doll, M. A., Hein, D. W., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.030 · Cited by 243 · cited 2×
“…that the excessive generation of ROS and herein particularly of nitric oxide (NO) and other reactive nitrogen species is involved in the development of various types of liver diseases ( e.g. , alcoholic liver disease, postischemic liver injury, viral hepatitis, and NASH) (14, 15, 18, 26, 41).”
Spruss, A., & Bergheim, I. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.05.006 · Cited by 162 · cited 2×
“Increased carbohydrate and in particular fructose intake has been discussed in recent years to be one of the key factors in the development of obesity, metabolic syndrome ( e.g. , insulin resistance and dyslipidemia), and NAFLD [for over-FIG view, also see (36)].”
The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice
Venkatraman, A., Shiva, S., Wigley, A., Ulasova, E., Chhieng, D., Bailey, S. M., & Darley-Usmar, V. M. (2004) · Hepatology · doi:10.1002/hep.20326 · Cited by 117
Cited by
In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
Kanuri, G., & Bergheim, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140611963 · Cited by 290
Self-citationCho, Y., Kim, D., Seo, W., Gao, B., Yoo, S., & Song, B. (2021) · Hepatology · doi:10.1002/hep.30652 · Cited by 254
Zhang, X., Zhang, J.-H., Chen, X.-Y., Hu, Q.-H., Wang, M.-X., Jin, R., Zhang, Q.-Y., Wang, W., Wang, R., Kang, L.-L., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5868 · Cited by 236
“7 macrophages, which are commonly used as a model for Kupffer cells, fructose stimulation also did not induce iNOS mRNA expression, nitrite formation, and inflammatory cytokines (48).”
BackgroundSpruss, A., Kanuri, G., Stahl, C., Bischoff, S. C., & Bergheim, I. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.75 · Cited by 168
Self-citationSong, B.-J., Akbar, M., Abdelmegeed, M. A., Byun, K., Lee, B., Yoon, S. K., & Hardwick, J. P. (2014) · Redox Biology · doi:10.1016/j.redox.2014.10.004 · Cited by 123
Role of immunodeficient animal models in the development of fructose induced NAFLD
Bhattacharjee, J., Kumar, J. M., Arindkar, S., Das, B., Pramod, U., Juyal, R. C., Majumdar, S. S., & Nagarajan, P. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.10.010 · Cited by 44
“Therefore, a better understanding of the biochemical and pathological changes that led to early stages of NAFLD is essential to develop therapeutic strategies [2].”
BackgroundLiu, Y., Han, X., Bian, Z., Peng, Y., You, Z., Wang, Q., Chen, X., Qiu, D., & Ma, X. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1902-9 · Cited by 35
Metadata
- Authors
- Spruss, A., Kanuri, G., Uebel, K., Bischoff, S. C., & Bergheim, I.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2011-06
- Volume
- 14
- Issue
- 11
- Pages
- 2121-2135
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2060440665
- Cited by
- 77
- References
- 10
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.